| Methods |
Randomized, double‐bind trial comparing 5‐ASA and SASP. Allocation of drugs was performed using a table of random numbers |
| Participants |
Patients with ulcerative colitis in remission (N = 13) |
| Interventions |
5‐ASA, 0.75 g/day (n = 7), or SASP, 1.5 g/day (n = 6) for a duration of 12 months |
| Outcomes |
The development of a new acute phase within 12 months from the beginning of the survey was considered a negative result |
| Notes |
Abstract |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Low risk |
Table of random numbers |
| Allocation concealment (selection bias) |
Unclear risk |
Not described |
| Blinding (performance bias and detection bias)
All outcomes |
Low risk |
Double‐blind |
| Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
Not described |
| Selective reporting (reporting bias) |
Unclear risk |
Not described |
| Other bias |
Unclear risk |
Not described |
